Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder.
Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder.
复制标题
DOI：
10.1016/j.jsat.2021.108387
复制
发表时间：
2021-10
影响因子：
3.9
通讯作者：
Shrestha R
中科院分区：
文献类型：
--
作者：
Mistler CB;Sullivan MC;Copenhaver MM;Meyer JP;Roth AM;Shenoi SV;Edelman EJ;Wickersham JA;Shrestha R
The COVID-19 pandemic has exacerbated health disparities, particularly among at-risk people with opioid use disorder (OUD). We sought to characterize the direct and indirect impacts of COVID-19 on this group to understand how the pandemic has affected this group, this group's public health response to COVID-19, and whether there were differences by race/ethnicity. This study recruited its sample from a drug treatment setting in the northeast region of the United States. We surveyed 110 individuals on methadone as treatment for OUD and assessed COVID-19-related impacts on their health behaviors and other indices of social, physical, and mental well-being, including sexual health behaviors, substance use, mental health status, health care access, income, and employment. Our findings highlight overall increases in depression, anxiety, loneliness, and frustration among the sample of people with OUD; the study also observed decreases in financial stability. Significant differences between groups indicated a greater financial burden among racial-ethnic minorities; this subgroup also reported greater direct adverse effects of COVID-19, including being more concerned about contracting COVID-19, not being able to get a COVID-19 test, and knowing someone who had died from COVID-19. A greater proportion of Whites indicated increases in alcohol consumption and non–prescription drug use than did racial-ethnic minorities. Treatment providers must be vigilant in managing direct and indirect outcomes of COVID-19 among people with OUD. Findings highlight the need to develop culturally competent, differentiated interventions in partnership with community-based organizations to meet the unique challenges that the COVID-19 pandemic presents for people in treatment for OUD.
登录
查看更多内容
影响因子：
2.3
作者：
Hyman, Scott M.;Fox, Helen;Sinha, Rajita
通讯作者：
Sinha, Rajita
影响因子：
4.2
作者：
Hoyt, Michael A.;Rubin, Lisa R.;Proeschold-Bell, Rae Jean
通讯作者：
Proeschold-Bell, Rae Jean
影响因子：
3.3
作者：
Dakil, Suzanne R.;Cox, Matthew;Flores, Glenn
通讯作者：
Flores, Glenn
影响因子：
4
作者：
Janevic, Mary R.;McLaughlin, Sara J.;Piette, John D.
通讯作者：
Piette, John D.
影响因子：
5.5
作者：
Ling W;Nadipelli VR;Aldridge AP;Ronquest NA;Solem CT;Chilcoat H;Albright V;Johnson C;Learned SM;Mehra V;Heidbreder C
通讯作者：
Heidbreder C